Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viatris Inc.

8.88
-0.3900-4.21%
Post-market: 8.890.0100+0.11%19:36 EDT
Volume:9.92M
Turnover:88.61M
Market Cap:10.42B
PE:-2.79
High:9.27
Open:9.24
Low:8.84
Close:9.27
Loading ...

Viatris Inc. Stock Falls 4.2%, Underperforms Market

Dow Jones
·
19 Jul

US FDA advisers vote against Otsuka's PTSD combination treatment

Reuters
·
19 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Independent Bank, Invesco

Reuters
·
19 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Eos Energy, Norfolk Southern, Coinbase

Reuters
·
19 Jul

Viatris Shares Fall 2.9% After Co's Eye Therapy Fails to Meet Late-Stage Trial Goal

THOMSON REUTERS
·
18 Jul

Sector Update: Health Care Stocks Edge Higher Pre-Bell Friday

MT Newswires Live
·
18 Jul

Viatris Stock Tumbles as Eyelid Inflammation Treatment Misses Target -- Barrons.com

Dow Jones
·
18 Jul

Viatris Fails to Meet Primary Endpoint of Phase 3 Study for Blepharitis Treatment

MT Newswires Live
·
18 Jul

Viatris Shares Fall 5% Premarket After Co's Eye Therapy Fails to Meet Late-Stage Trial Goal

THOMSON REUTERS
·
18 Jul

Viatris eye therapy fails to meet late-stage trial goal

Reuters
·
18 Jul

Viatris Inc. Announces Positive Results from Phase 3 Trials of MR-142 and MR-141, and Provides Update on MR-139 Study for Blepharitis

Reuters
·
18 Jul

Viatris Provides Update on Phase 3 Study of Mr-139 for Blepharitis

THOMSON REUTERS
·
18 Jul

Viatris Inc - Evaluating Next Steps for Phase 3 Program

THOMSON REUTERS
·
18 Jul

Viatris Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
17 Jul

Viatris (VTRS) Receives a Hold from Goldman Sachs

TIPRANKS
·
16 Jul

FDA staff raises efficacy concerns for Otsuka's PTSD combination drug

Reuters
·
16 Jul

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
16 Jul

GSK Viiv Extends Cabotegravir Licensing Deal to Include HIV Treatment

MT Newswires Live
·
14 Jul

Viatris Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
12 Jul

BRIEF-FDA Discontinues Mylan Pharmaceuticals' Potassium Chloride Tablet

Reuters
·
09 Jul